Ventral medial prefrontal cortex (vmPFC) as a target of the dorsolateral prefrontal modulation by transcranial direct current stimulation (tDCS) in drug addiction

被引:0
作者
Ester Miyuki Nakamura-Palacios
Isabela Bittencourt Coutinho Lopes
Rodolpho Albuquerque Souza
Jaisa Klauss
Edson Kruger Batista
Catarine Lima Conti
Janine Andrade Moscon
Rodrigo Stênio Moll de Souza
机构
[1] Universidade Federal do Espírito Santo,Laboratory of Cognitive Sciences and Neuropsychopharmacology, Programa de Pós
[2] Federal University of Espírito Santo,Graduação em Ciências Fisiológicas, Centro de Ciências da Saúde
来源
Journal of Neural Transmission | 2016年 / 123卷
关键词
Transcranial direct current stimulation; Dorsolateral prefrontal cortex; Ventral medial prefrontal cortex; Drug addiction; Alcohol; Crack-cocaine;
D O I
暂无
中图分类号
学科分类号
摘要
Here, we report some electrophysiologic and imaging effects of the transcranial direct current stimulation (tDCS) over the dorsolateral prefrontal cortex (dlPFC) in drug addiction, notably in alcohol and crack-cocaine dependence. The low resolution electromagnetic tomography (LORETA) analysis obtained through event-related potentials (ERPs) under drug-related cues, more specifically in its P3 segment (300–500 ms) in both, alcoholics and crack-cocaine users, showed that the ventral medial prefrontal cortex (vmPFC) was the brain area with the largest change towards increasing activation under drug-related cues in those subjects that kept abstinence during and after the treatment with bilateral tDCS (2 mA, 35 cm2, cathodal left and anodal right) over dlPFC, applied repetitively (five daily sessions). In an additional study in crack-cocaine, which showed craving decreases after repetitive bilateral tDCS, we examined data originating from diffusion tensor imaging (DTI), and we found increased DTI parameters in the left connection between vmPFC and nucleus accumbens (NAcc), such as the number of voxels, fractional anisotropy (FA) and apparent diffusion coefficient (ADC), in tDCS-treated crack-cocaine users when compared to the sham-tDCS group. This increasing of DTI parameters was significantly correlated with craving decreasing after the repetitive tDCS. The vmPFC relates to the control of drug seeking, possibly by extinguishing this behavior. In our studies, the bilateral dlPFC tDCS reduced relapses and craving to the drug use, and increased the vmPFC activation under drug cues, which may be of a great importance in the control of drug use in drug addiction.
引用
收藏
页码:1179 / 1194
页数:15
相关论文
共 338 条
  • [1] Anderer P(2000)Effect of the 5-HT(1A) partial agonist buspirone on regional brain electrical activity in man: a functional neuroimaging study using low-resolution electromagnetic tomography (LORETA) Psychiatry Res 100 81-96
  • [2] Saletu B(2007)The treatment of alcohol dependence Curr opin psychiatry 20 222-227
  • [3] Pascual-Marqui RD(2015)A randomized placebo-controlled trial of targeted prefrontal cortex modulation with bilateral tDCS in patients with crack-cocaine dependence Int J Neuropsychopharmacol 10 69-76
  • [4] Assanangkornchai S(1993)P3 in young boys as a predictor of adolescent substance use Alcohol 112 220-225
  • [5] Srisurapanont M(2010)Modulation of risk-taking in marijuana users by transcranial direct current stimulation (tDCS) of the dorsolateral prefrontal cortex (DLPFC) Drug Alcohol Depend 26 376-386
  • [6] Batista EK(2002)Neural systems and cue-induced cocaine craving Neuropsychopharmacology 14 1133-1145
  • [7] Klauss J(2011)A systematic review on reporting and assessment of adverse effects associated with transcranial direct current stimulation Int J Neuropsychopharmacol 32 90-98
  • [8] Fregni F(2011)Sertraline vs. electrical current therapy for treating depression clinical trial–SELECT TDCS: design, rationale and objectives Contemp Clin Trials 5 175-195
  • [9] Nitsche MA(2012)Clinical research with transcranial direct current stimulation (tDCS): challenges and future directions Brain Stimul 125 298-305
  • [10] Nakamura-Palacios EM(2014)Comparison of blinding effectiveness between sham tDCS and placebo sertraline in a 6-week major depression randomized clinical trial Clin Neurophysiol 7 232-408